Teva to face inhaler infringement allegations in UK court
03-06-2020
EU General Court sides with Merck in TM opposition
21-11-2019
nitpicker / Shutterstock.com
Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Chiesi Farmaceutici, Nitto Pharmaceutical Industries, Noster, Foster, Fostair, inhaler, Teva, generics, EU General Court, brand, trademark, EUIPO
